Clinical Trial

Short-course High-dose Prednisone and Dexamethasone in Children With ITP

Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated May 16, 2024 (before its estimated August 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
Comparison of the efficacy and safety of short-course high-dose prednisone and dexamethasone in the treatment of children with newly diagnosed immune thrombocytopenia (ITP)
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2022-08-29; most recent amendment 2024-05-14.
Trial Details
NCT Number NCT05522465
Lead Sponsor Fujian Medical University Union Hospital
Collaborators: The First Affiliated Hospital of Xiamen University, Zhangzhou Affiliated Hospital of Fujian Medical University, Quanzhou First Hospital, Nanping First Hospital Affiliated to Fujian Medical University, The Second Hospital of Anhui Medical University, The Affiliated Hospital Of Guizhou Medical University, Longyan City First Hospital, The Affiliated Hospital of Putian University
Conditions Immune Thrombocytopenia, Glucocorticoids, Child, Only
Enrollment 608 participants
Start Date 2022-10-11
Primary Completion 2025-08-31 (estimated)
Study Completion 2026-08-31 (estimated)
Updated on ClinicalTrials.gov 2024-05-16